Patent 7784460 was granted and assigned to OptiNose on August, 2010 by the United States Patent and Trademark Office.
A delivery device, in particular a breath-actuated nasal delivery device, for delivering substance, in particular one of a liquid, as a suspension or solution, or a powder containing a medicament, especially systemic or topical pharmaceuticals, or a vaccine to the nasal airway of a subject.